Publisert 27.11.2018

Adam Robertson new Chief Scientific Officer in Regenics

 Adam Robertson has today signed up as  Business Developer for Regenics AS.

 Adam is part of the team that develops cutting  edge skin care and wound healing at Regenics.  Adam is a   formally trained biochemist. He  received his PhD from the University of North Carolina at Chapel Hill,   USA, where he studied DNA repair mechanisms. During his post-doctoral work at the University of Oslo he   helped to elucidate a new mechanism of DNA replication licensing. This work led to his appointment as a   laboratory group leader; in this role, he led a team of researchers to develop new cancer therapeutics.

 

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.